CHRISTINE KULLE: Open Payments
NPI 1306154976 · CAMPBELL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 16 payments from 7 companies in 2025. Trend: 2023 $817 · 2024 $715 · 2025 $419
Food & beverage: $340Education: $79
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $217 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $52 |
| Exact Sciences Corporation | 2 | $47 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Biogen, Inc. | 1 | $24 |
| MILLICENT US INC | 1 | $24 |
| Organon LLC | 1 | $21 |
Products named: Veozah, Cologuard Collection Kit, ZURZUVAE, FEMLYV, NEXPLANON, MYFEMBREE, GEMTESA.
Industry payments across CA — which companies pay providers there.
